Laparoscopic assisted vaginal hysterectomy
ProcedureSurgical removal of uterus vaginally
NCT Number: NCT01217866
Retrospective charts review from one surgeon to compare Group A- cases where the laparoscopic portion of the case used an EN~SEAL device to Group B - the laparoscopic BSO was done using a 3mm EN-SEAL device through 2 lateral 5mm ports.
Looking for future studies?
Notify Me35 year–75 year
Female
Observational
79 women with benign uterine disease underwent laparoscopic assisted vaginal hysterectomy with or without bilateral salpingo-oophorectomy. Subjects charts were divided into two groups based on surgical technique and the following parameters were reviewed retrospectively: surgical time, blood loss, uterine weight, patient weight, patient age, post operative fever >100.4 F, readmission to hospital within one week, return to operating room within 24 hours, length of hospital stay, and blood transfusion. Group A, N=35 used traditional suture technique vaginally. Group B, N=44 used Enseal coagulation cutting device vaginally.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Surgical removal of uterus vaginally
Time frame: Operating room time in minutes
The total time the subject spent in surgery was compared between the two groups
Time frame: Blood loss during surgery in cc per minute
The total blood loss in cc per minutes operating was compared between the two groups
Womens Care
Other
A Retrospective Analysis of a Complete Enseal Laparoscopic Vaginal Assisted Hysterectomy Versus a Traditional Suture Laparoscopic Vaginal Hysterectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02065453
Benign Uterine Disease
St Louis, Missouri, United States
View Trial DetailsNCT01893086
Benign Uterine Disease
Daegu, South Korea
View Trial DetailsNCT01861067
Benign Uterine Disease
Seoul, South Korea
View Trial DetailsNCT01880710
Benign Uterine Disease, Female Urogenital Diseases
Nykoebing Falster, Region Sjælland, Denmark
View Trial Details